Vaccine and Booster Update

October 21, 2021: The Centers for Disease Control and Prevention endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for COVID-19 booster vaccines in certain populations and points to the announcement and authorization by the Food and Drug Administration last week which states:

• • The use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series to individuals:
    • 65 years of age and older
    • 18 through 64 years of age at high risk of severe COVID-19
    • 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2
  • The use of a single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.
  • A single booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered at least 6 months after completion of the primary series to individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2. See September’s United Spinal update on the Pfizer vaccine.
  • Each of the available COVID-19 vaccines can be used as booster shots even if you did not receive a particular vaccine as part of your primary vaccination.

November 2, 2021: The Centers for Disease Control and Prevention endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation that children 5 to 11 years old be vaccinated against COVID-19 with the Pfizer-BioNTech Pediatric Vaccine. CDC now expands vaccine recommendations to about 28 million children in the United States in this age group and allows providers to begin vaccinating them as soon as possible. 

Visit the CDC and FDA websites for more information.

If you have any questions, United Spinal recommends you speak with your own healthcare provider.